Back
Aurinia Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58
AUPH
Aurinia Pharmaceuticals
Last Price:
$9.08
Seasonality Move:
-5.15%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AUPH is experiencing selling pressure, which indicates risk of future bearish movement.
Aurinia Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.51 | Buy |
| 20-day SMA: | 8.19 | Buy |
| 50-day SMA: | 8.14 | Buy |
| 200-day SMA: | 8.09 | Buy |
| 8-day EMA: | 8.63 | Buy |
| 20-day EMA: | 8.34 | Buy |
| 50-day EMA: | 8.18 | Buy |
| 200-day EMA: | 7.9 | Buy |
Aurinia Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 60.62 | Buy |
| Chaikin Money Flow: | -1160897 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.7 - 8.68) | Buy |
| Bollinger Bands (100): | (7.74 - 8.44) | Buy |
Aurinia Pharmaceuticals Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aurinia Pharmaceuticals Stock
Is Aurinia Pharmaceuticals Stock a Buy?
-
Aurinia Pharmaceuticals share price is 8.85 while AUPH 8-day simple moving average is 8.51, which is a Buy signal.
-
The stock price of AUPH is 8.85 while Aurinia Pharmaceuticals 20-day SMA is 8.19, which makes it a Buy.
-
Aurinia Pharmaceuticals 50-day simple moving average is 8.14 while AUPH share price is 8.85, making it a Buy technically.
-
AUPH stock price is 8.85 and Aurinia Pharmaceuticals 200-day simple moving average is 8.09, creating a Buy signal.
AUPH Technical Analysis vs Fundamental Analysis
Buy
58
Aurinia Pharmaceuticals (AUPH)
is a Buy
Is Aurinia Pharmaceuticals a Buy or a Sell?
-
Aurinia Pharmaceuticals stock is rated a BuyThe current Aurinia Pharmaceuticals [AUPH] share price is $8.85. The Score for AUPH is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Aurinia Pharmaceuticals Stock Info
Market Cap:
1.2B
Price in USD:
8.85
Share Volume:
1.2M
Aurinia Pharmaceuticals 52-Week Range
52-Week High:
10.67
52-Week Low:
5.20
Buy
58
Aurinia Pharmaceuticals (AUPH)
is a Buy
Aurinia Pharmaceuticals Share Price Forecast
-
What is the Aurinia Pharmaceuticals stock price today?The Aurinia Pharmaceuticals stock price is 8.85 USD today.
-
Will AUPH stock go up or go down?Aurinia Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Aurinia Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aurinia Pharmaceuticals is not overvalued.
Is Aurinia Pharmaceuticals Stock a Buy?
-
Aurinia Pharmaceuticals share price is 8.85 while AUPH 8-day exponential moving average is 8.63, which is a Buy signal.
-
The stock price of AUPH is 8.85 while Aurinia Pharmaceuticals 20-day EMA is 8.34, which makes it a Buy.
-
Aurinia Pharmaceuticals 50-day exponential moving average is 8.18 while AUPH share price is 8.85, making it a Buy technically.
-
AUPH stock price is 8.85 and Aurinia Pharmaceuticals 200-day simple moving average is 7.90, creating a Buy signal.
Fundamental Analysis of Aurinia Pharmaceuticals
Is Aurinia Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.56 per share, and an increase next year of $0.17 per share.
Technical Analysis of Aurinia Pharmaceuticals
Should I short Aurinia Pharmaceuticals stock?
-
AUPH Moving Average Covergence Divergence (MACD) indicator is 0.21, suggesting Aurinia Pharmaceuticals is a Buy
-
Aurinia Pharmaceuticals Relative Strength Index (RSI) is 60.62, which suggest Aurinia Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Aurinia Pharmaceuticals is (7.7 - 8.68), which suggest Aurinia Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Aurinia Pharmaceuticals is (7.74 - 8.44), which suggest Aurinia Pharmaceuticals is a Buy
* Aurinia Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.